IGF1R is emerging as an important gene in the pathogenesis of many solid and haematolo-gical cancers and its over-expression has been reported as frequently associated with ag-gressive disease and chemotherapy resistance. In this study we performed an investigation of the role of IGF1R expression in a large and representative prospective series of 217 chronic lymphocytic leukaemia (CLL) patients enrolled in the multicentre O-CLL1 protocol (clinicaltrial.gov #NCT00917540). High IGF1R gene expression was significantly associat-ed with IGHV unmutated (IGHV-UM) status (p<0.0001), high CD38 expression (p<0.0001), trisomy 12 (p<0.0001), and del(11)(q23) (p=0.014). Interestingly, higher IGF1R expression (p=0.002) characterized patients wi...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment...
Background: Accumulating evidence suggests that insulin-like growth factor (IGF) signaling is an imp...
<div><p><i>IGF1R</i> is emerging as an important gene in the pathogenesis of many solid and haematol...
IGF1R is emerging as an important gene in the pathogenesis of many solid and haematological cancers ...
Background: Alterations in the insulin-like growth factor (IGF) system have been reported for differ...
PURPOSE: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Purpose: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
International audienceBackground : The tyrosine kinase receptor insulin-like growth factor 1 recepto...
Infantile hemangioma (IH) is the most common tumor of the pediatric age group, affecting up to 4 % o...
OBJECTIVES: Insulin-like growth factor 1 (IGF-1) is an important growth and anti-apoptotic factor fo...
Contains fulltext : 165680.pdf (publisher's version ) (Open Access)BACKGROUND: The...
PURPOSE: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Objective: Chronic lymphocytic leukemia (CLL) is a disease of nonproliferating and mature-appearing ...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment...
Background: Accumulating evidence suggests that insulin-like growth factor (IGF) signaling is an imp...
<div><p><i>IGF1R</i> is emerging as an important gene in the pathogenesis of many solid and haematol...
IGF1R is emerging as an important gene in the pathogenesis of many solid and haematological cancers ...
Background: Alterations in the insulin-like growth factor (IGF) system have been reported for differ...
PURPOSE: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Purpose: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
International audienceBackground : The tyrosine kinase receptor insulin-like growth factor 1 recepto...
Infantile hemangioma (IH) is the most common tumor of the pediatric age group, affecting up to 4 % o...
OBJECTIVES: Insulin-like growth factor 1 (IGF-1) is an important growth and anti-apoptotic factor fo...
Contains fulltext : 165680.pdf (publisher's version ) (Open Access)BACKGROUND: The...
PURPOSE: B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease whose outco...
Objective: Chronic lymphocytic leukemia (CLL) is a disease of nonproliferating and mature-appearing ...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment...
Background: Accumulating evidence suggests that insulin-like growth factor (IGF) signaling is an imp...